Blog
RSS FeedPosted by Michael Wonder on 11 Nov 2019
Lipocine receives complete response letter for Tlando from U.S. FDA
11 November 2019 - Lipocine announced today that it has received a complete response letter from the United States Food ...
Posted by Michael Wonder on 05 Nov 2019
Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar Ziextenzo (pegfilgrastim-bmez)
5 November 2019 - Ziextenzo is indicated to decrease the incidence of febrile neutropenia, one of the most serious side effects ...
Posted by Michael Wonder on 23 Oct 2019
Blair had private health insurance — but his cancer treatment still cost almost $1,000 a week
24 October 2019 - It is Anzac Day 2017, and Blair Meldrum cannot get out of bed. ...
Posted by Michael Wonder on 03 Oct 2019
Trump to unveil order aiming to boost Medicare health program, woo seniors
3 October 2019 - U.S. President Donald Trump will unveil an executive order on Thursday aimed at strengthening the Medicare health ...
Posted by Michael Wonder on 25 Sep 2019
Trump Administration drives down Medicare Advantage and Part D premiums for seniors
24 September 2019 - Medicare Advantage premiums projected to go down to their lowest level in 13 years ...
Posted by Michael Wonder on 24 Sep 2019
This is what Medicare Part D has done to prescription costs
23 September 2019 - Medicare Part D, the optional prescription drug benefit plan, was introduced in 2006. ...
Posted by Michael Wonder on 23 Sep 2019
U.S. voters support expanding Medicare but not eliminating private health insurance
22 September 2019 - Ideas like Medicare for All are embraced by most Democratic voters but could challenge the party in ...
Posted by Michael Wonder on 18 Sep 2019
Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes
18 September 2019 - As controversy continues over prescription drug pricing, a new study finds that Medicare Part D spent ...
Posted by Michael Wonder on 17 Sep 2019
Price controls for Medicare don't put America first
17 September 2019 - Instead of embracing drug price controls, the U.S. should pressure other nations to abandon them. ...
Posted by Michael Wonder on 12 Sep 2019
When are RCTs required for breakthrough drugs, HDEs? JAMA study investigates
11 September 2019 - A new study in JAMA Network Open finds that drugs and medical devices approved by the ...
Posted by Michael Wonder on 11 Sep 2019
How to correct this big Medicare mistake
10 September 2019 - It's a big mistake to assume that Medicare is the only health insurance you need in ...
Posted by Michael Wonder on 09 Sep 2019
Bernie Sanders went to Canada, and a dream of ‘Medicare for all’ flourished
9 September 2019 - The Vermont senator has staked his presidential campaign, and much of his political legacy, on transforming health ...
Posted by Michael Wonder on 05 Sep 2019
Medicare drug price negotiation — why now . . . and how
4 September 2019 - A targeted bargaining strategy using tried and tested arbitration techniques could help Medicare balance drug innovation and ...
Posted by Michael Wonder on 04 Sep 2019
Proposals to redesign Medicare Part D — easing the burden of rising drug prices
4 September 2019 - Amid concerns about high drug prices, policy makers are considering options for modifying the Medicare Part D ...
Posted by Michael Wonder on 28 Aug 2019
Promoting paediatric drug research and labelling — outcomes of legislation
28 August 2019 - Congress has modified regulations of the FDA to promote research assessing the efficacy and safety of drugs ...